Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
clara.nervi@uniroma1.it
Clara Nervi
Professore Ordinario
Struttura:
DIPARTIMENTO DI SCIENZE E BIOTECNOLOGIE MEDICO-CHIRURGICHE
E-mail:
clara.nervi@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
A novel AML1-ETO/FTO positive feedback loop promotes leukemogenesis and Ara-C resistance via stabilizing IGFBP2 in t(8;21) acute myeloid leukemia
EXPERIMENTAL HEMATOLOGY & ONCOLOGY
2024
MCL1 regulates AML cells metabolism via direct interaction with HK2. Metabolic signature at onset predicts overall survival in AMLs' patients
LEUKEMIA
2023
Editorial: Genetic/epigenetic mechanisms and related clinical strategy in leukemia
FRONTIERS IN ONCOLOGY
2023
Biomarkers in acute myeloid leukemia: From state of the art in risk classification to future challenges of RNA editing as disease predictor and therapy target
ASPECTS OF MOLECULAR MEDICINE
2023
Ascorbate plus buformin in AML. A metabolic targeted treatment
CANCERS
2022
A tribute to professor Sergio Adamo, full professor of histology and embryology at Sapienza university, Rome
EUROPEAN JOURNAL OF TRANSLATIONAL MYOLOGY
2022
Serum albumin and nucleic acids biodistribution. From molecular aspects to biotechnological applications
IUBMB LIFE
2022
The gene promoter binding activity of miR-223 induces flotillin-1 expression and function to regulate myeloid differentiation
HAEMATOLOGICA
2022
Ascorbate plus buformin in AML: a metabolic targeted treatment
CANCERS
2022
Thalassemias. From gene to therapy
MOLECULAR ASPECTS OF MEDICINE
2021
Molecular imaging in immuno-oncology: current status and translational perspectives
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
2020
Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells
CELLS
2020
Aptamer-based technology for radionuclide targeted imaging and therapy: a promising weapon against cancer
EXPERT REVIEW OF MEDICAL DEVICES
2020
Genetic lesions disrupting calreticulin 3′-untranslated region in JAK2 mutation-negative polycythemia vera
AMERICAN JOURNAL OF HEMATOLOGY
2020
Ruxolitinib binding to human serum albumin. Bioinformatics, biochemical and functional characterization in JAK2V617F+ cell models
SCIENTIFIC REPORTS
2019
ISTOLOGIA di Monesi
ISTOLOGIA di Monesi
2018
Are DNA damage response kinases a target for the differentiation treatment of acute myeloid leukemia?
IUBMB LIFE
2018
HDAC inhibition by valproic acid decreases JAK2V617F levels in myeloproliferative neoplasms via up-regulation of miR-101, in vivo and in vitro
HEMASPHERE
2018
A novel germline CALR mutation affecting an evolutionary conserved region of 3’UTR in JAK2-negative siblings with Polycythemia Vera
HEMASPHERE
2018
A novel germline mutation in the 3'Untranslated region of Calreticulin gene induces JAK/STAT signaling activation and Erythrocytosis.
HAEMATOLOGICA
2018
1
2
seguente ›
ultima »
Progetti di Ricerca
Identification of epigenetic interactors of calreticulin 3'-untranslated mRNA region in normal hematopoiesis and myeloproliferative neoplasms
Biological role of genomic chromatin targeting by microRNA in normal and neoplastic hematopoiesis
Functional significance of Calreticulin 3-untranslated region in normal hematopoiesis and myeloproliferative neoplasms
Laboratori di ricerca
LABORATORIO CON LIVELLO DI BIOSICUREZZA 2 (P2)
LABORATORIO DIDATTICO DI SIMULAZIONE E ADDESTRAMENTO. SKILL LAB.
LABORATORIO EMOPOIESI E LEUCEMOGENESI
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma